|
The Virginia Center for Allergy & Asthma - NIH Asthma Update 2007 |
NIH Asthma Update 2007 Key Differences from 2002 ReportInitial Assessment – Classify severity to initiate control Frequent Monitoring – Assess control on an ongoing basis and adjust therapy as necessary Severity – The intrinsic intensity of the disease process (ideally measured at initial presentation) Control – The degree to which the manifestations of asthma are minimized and goals of therapy are met Both severity and control have 2 domains: Impairment – frequency and intensity of symptoms and functional limitations the patient is experiencing Risk – likelihood of either asthma exacerbations, progressive decline in lung function or risk of adverse events Goals of Asthma Control:
- Reduce impairment:
- Prevent chronic symptoms
- Require infrequent use of inhaled SABA (less than 1x/wk)
- Maintain “normal” pulmonary function
- Maintain normal activity levels
- Meet patients’ and families’ expectations of asthma care
Reduce risk:
- Prevent recurrent exacerbations and minimize need for ED visits
- Prevent progressive loss of lung function
- Provide optimal pharmacotherapy with minimal or no adverse side effects
- Periodic assessments (every 1-6 months) and ongoing monitoring of asthma control
|